Which antiplatelet agent? The debate intensifies
Plavix (clopidogrel) has been a blockbuster drug. The lower cost of generic clopidogrel, available for the first time since 17 May 2012 , is intensifying debate among cardiologists over how to make sure patients get optimal benefit from any blood-..
Original Article: Which antiplatelet agent? The debate intensifiesNEXT ARTICLE